Laryngeal squamous cell carcinoma – Diagnostics – Overview of Information and Clinical Research

Laryngeal squamous cell carcinoma is diagnosed through a careful process that helps doctors understand what is happening in your throat and voice box. Finding the cancer early and understanding its extent helps guide the best treatment path for each person.

Introduction: When Should You Seek Diagnostic Testing?

If you notice changes in your voice that last longer than two weeks, particularly hoarseness that doesn’t improve, it’s important to consult a healthcare provider. Many people dismiss these early signs as nothing more than a lingering cold or throat irritation, but persistent symptoms deserve attention. Early detection of laryngeal cancer can make a significant difference in treatment outcomes and the preservation of your voice and quality of life.^[1]

You should seek medical evaluation if you experience a sore throat or cough that won’t go away, pain or difficulty when swallowing, a lump in your neck or throat, trouble making voice sounds, or ear pain that persists. These symptoms can be caused by many conditions, but only proper diagnostic testing can determine the underlying cause.^[1]

Certain symptoms require immediate medical attention. If you develop trouble breathing, noisy and high-pitched breathing called stridor (an abnormal, high-pitched sound during breathing), the sensation that something is stuck in your throat, or if you cough up blood, seek medical help right away. These symptoms may indicate that the cancer is affecting your ability to breathe or has reached a more advanced stage.^[1]

People who smoke, use other tobacco products, or drink alcohol heavily are at higher risk and should be especially vigilant about any changes in their throat or voice. Those over age 55, particularly men, also face increased risk. If you work with certain substances like sulfuric acid mist, wood dust, nickel, or asbestos, or if you’ve had head and neck cancer before, you should discuss regular monitoring with your doctor.^[1]

⚠️ Important

Don’t wait for symptoms to become severe. Cancers that start in the glottis, where your vocal cords are located, often cause hoarseness early on, making them easier to detect. However, cancers in other parts of the larynx may not cause obvious symptoms until they grow larger. Regular check-ups and prompt attention to any throat or voice changes are your best defense.

Classic Diagnostic Methods

When you first visit a healthcare provider with concerns about your throat or voice, they will begin with a thorough conversation about your symptoms and medical history. This includes asking about how long you’ve had symptoms, whether they’re getting worse, your smoking and alcohol use, your work environment, and whether you’ve had cancer before. This information helps the doctor understand your risk factors and guides the next steps in diagnosis.^[1]

The initial physical examination includes a careful inspection of your throat and neck. Your doctor will feel the inside of your mouth with a gloved finger and use a small mirror with a light to examine your mouth, throat, and the back of your tongue. They will also feel your neck for any lumps or swollen lymph nodes (small, bean-shaped structures that are part of your immune system and can become enlarged when cancer spreads). This basic exam can reveal obvious problems, but more detailed testing is usually necessary to confirm a diagnosis.^[1]

Laryngoscopy and Biopsy

A more detailed look at your larynx requires a procedure called laryngoscopy. During this examination, the doctor uses a special instrument to view your larynx directly. There are different types of laryngoscopy. An indirect laryngoscopy uses a small mirror placed in the back of your throat, while a direct laryngoscopy involves inserting a thin, lighted tube called a laryngoscope through your mouth or nose to get a closer view. Direct laryngoscopy often provides the clearest view and allows the doctor to take tissue samples.^[1]

The most important part of diagnosing laryngeal cancer is the biopsy, where a small piece of tissue is removed from any suspicious area and examined under a microscope by a specialist called a pathologist. This is the only way to definitively confirm whether cancer is present and determine what type of cells are involved. Most laryngeal cancers are squamous cell carcinomas, meaning they develop from the flat, thin cells that line the inside of the larynx. The biopsy can be done during direct laryngoscopy, often under general anesthesia so you won’t feel anything.^[2]^[3]

Imaging Scans

Once cancer is confirmed, imaging tests help doctors understand how large the tumor is and whether it has spread beyond the larynx. CT scans (computed tomography) use X-rays to create detailed, three-dimensional pictures of the inside of your body. A CT scan can show the exact size and location of the tumor, whether it has grown into nearby structures like the thyroid gland or food pipe, and whether lymph nodes in your neck are enlarged, which might mean the cancer has spread.^[1]

MRI scans (magnetic resonance imaging) use powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues. MRI is particularly good at showing the extent of the tumor in soft tissue and can help doctors plan surgery or other treatments. Some patients may have both CT and MRI scans because each provides different types of information that together give a complete picture.^[1]

PET scans (positron emission tomography) may be used in some cases, especially if doctors suspect the cancer has spread to other parts of the body. During a PET scan, a small amount of radioactive sugar is injected into your vein. Cancer cells, which use more energy than normal cells, absorb more of this sugar and show up as bright spots on the scan. PET scans are sometimes combined with CT scans in a single test called a PET-CT scan to provide both anatomical and metabolic information.^[1]

Assessment of Lymph Nodes

The larynx has a rich network of lymphatic vessels, particularly in the upper part called the supraglottis. This means cancer can spread to nearby lymph nodes. The vocal cords themselves, however, have very few lymphatic vessels, so cancer confined only to the vocal cords rarely spreads to lymph nodes at first. Understanding whether lymph nodes are involved is crucial because it affects the stage of cancer and treatment decisions.^[4]

If lymph nodes in your neck appear enlarged on physical examination or imaging scans, your doctor may recommend a fine-needle aspiration or biopsy of the lymph node. During fine-needle aspiration, a thin needle is inserted into the enlarged node to remove cells for examination under a microscope. This helps confirm whether the cancer has spread to the lymph nodes. Between 25 and 50 percent of patients with supraglottic cancer have lymph node involvement at the time of diagnosis, depending on the size of the original tumor.^[4]

Staging After Diagnosis

After all the tests are completed, your doctor will assign a stage to your cancer. Staging describes how large the cancer is and how far it has spread. The larynx is divided into three main areas: the supraglottis (upper part), the glottis (middle part where the vocal cords are), and the subglottis (lower part). Each area has its own staging system because cancers behave differently depending on where they start.^[4]

More than half of laryngeal cancers—about 60 percent—start in the glottis where the vocal cords are located. About 35 percent start in the supraglottis, and only about 5 percent start in the subglottis. Knowing which area is affected helps doctors predict how the cancer might spread and choose the best treatment approach.^[1]

Stage 1 means the cancer is only in one part of the larynx and the vocal cords can still move normally. The cancer hasn’t spread to nearby tissues, lymph nodes, or other organs. Stage 2 indicates the cancer has grown into another part of the larynx from where it started, and in some cases the vocal cords may not be able to move. Stage 3 means the cancer has grown throughout the larynx or one vocal cord is fixed and can’t move, or it may have spread to one nearby lymph node no larger than 3 centimeters. Stage 4 indicates the cancer may have spread into tissues outside the larynx, to larger or more distant lymph nodes, or to other parts of the body.^[17]

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial (a research study testing new treatments), you’ll need to undergo specific diagnostic tests to determine whether you’re eligible. Clinical trials have strict criteria about who can participate, based on the stage and characteristics of the cancer, your overall health, and sometimes even specific features of the tumor cells. These requirements ensure the trial can accurately measure whether the new treatment works and is safe.^[4]

Before enrolling in a clinical trial, you’ll typically need confirmation of your cancer diagnosis through biopsy. The tissue samples are examined not just to confirm cancer, but to determine the exact type and grade (how abnormal the cells look under a microscope). High-grade tumors have cells that look very different from normal cells and tend to grow faster. Some trials only accept patients with certain grades of cancer.^[4]

Imaging tests like CT, MRI, or PET scans are essential for trial enrollment because they document the exact size and location of your tumor. Researchers need this baseline information to measure whether the tumor shrinks, stays the same, or grows during the trial. Many trials require recent scans—often taken within a few weeks of enrollment—to ensure the measurements are accurate and up to date.^[4]

Blood tests are another standard requirement for clinical trial participation. These tests check your overall health and how well your organs are functioning. Trials often require that your liver, kidneys, and bone marrow are working well enough to handle the treatment being tested. Blood tests also provide baseline measurements of various markers that can be monitored throughout the trial to watch for side effects or signs of how the treatment is working.^[4]

Some clinical trials require specialized testing beyond standard diagnostics. For instance, if a trial is testing a targeted therapy (a treatment that attacks specific features of cancer cells), you may need molecular testing of your tumor. This involves analyzing the cancer cells to look for specific genetic changes or proteins that the treatment targets. Not everyone’s cancer has these features, so this testing helps identify who is most likely to benefit from the experimental treatment.^[4]

Your performance status—a measure of how well you can carry out daily activities—is also assessed for trial eligibility. This is usually measured on a scale, with lower numbers indicating better function. Trials typically require that you’re well enough to take care of yourself and are active for at least part of the day. This ensures you’re healthy enough to tolerate the experimental treatment and complete the study.^[4]

⚠️ Important

Clinical trials offer access to new treatments that aren’t yet widely available. However, not everyone qualifies for every trial. If you’re interested in participating, talk to your healthcare team about which trials might be appropriate for your specific situation. They can help you understand the eligibility requirements and what additional testing might be needed.

Throughout a clinical trial, you’ll undergo regular testing to monitor how you’re responding to treatment. This often includes repeated imaging scans at specific intervals, frequent blood tests, and ongoing physical examinations. These tests serve two purposes: they help researchers understand whether the treatment is working, and they allow your doctors to quickly identify and address any side effects or complications.^[4]

Prognosis and Survival Rate

Prognosis

The outlook for people with laryngeal squamous cell carcinoma depends on several important factors. The most significant factor affecting prognosis is the stage of cancer when it’s discovered. Small cancers that haven’t spread to lymph nodes have a very good prognosis, with cure rates ranging from 75 to 95 percent depending on the location and size of the tumor. Early-stage laryngeal cancer, particularly when confined to the vocal cords, is often highly curable with single treatments like surgery or radiation therapy, and many patients can keep their voice box intact.^[4]^[7]

The specific part of the larynx where the cancer starts also affects prognosis. Cancers of the glottis, where the vocal cords are located, tend to be detected earlier because they cause noticeable voice changes quickly. This early detection generally leads to better outcomes. Cancers in the supraglottis or subglottis may grow larger before causing symptoms, which can result in more challenging treatment and a different prognosis.^[4]

Other factors that influence prognosis include whether the cancer has spread to lymph nodes (designated as the N stage), your age, sex, overall physical health, and certain characteristics of the tumor cells themselves, such as their grade and how deeply they’ve invaded surrounding tissues. People who continue to smoke and drink alcohol after diagnosis face a lower chance of cure and higher risk of developing a second cancer. Many patients in this population also face serious health problems from smoking and alcohol use, and some die from other illnesses rather than the cancer itself.^[4]^[12]

For more advanced cancers that have spread beyond the larynx or to multiple lymph nodes, the prognosis is more guarded. These cancers typically require multimodal therapy combining surgery, radiation, and chemotherapy. Advanced stage disease often necessitates more extensive treatment that may not preserve the larynx, affecting quality of life. However, treatment approaches continue to improve, and many people with advanced laryngeal cancer can still achieve good outcomes with comprehensive care.^[4]

Survival rate

Survival statistics for laryngeal squamous cell carcinoma vary significantly by stage at diagnosis. For Stage 1 laryngeal cancer, where the disease is confined to one part of the larynx and hasn’t spread, almost 90 out of 100 people (almost 90 percent) survive for five years or more after diagnosis. This excellent survival rate reflects the high curability of early-stage disease.^[17]

For Stage 2 cancer, where the tumor has grown into another part of the larynx but hasn’t spread to lymph nodes or other organs, around 70 out of 100 people (around 70 percent) survive for five years or more. While this represents a decrease from Stage 1, it still indicates that most people with Stage 2 disease can achieve long-term survival with appropriate treatment.^[17]

Stage 3 laryngeal cancer has a five-year survival rate of almost 55 out of 100 adults (almost 55 percent). At this stage, the cancer has grown throughout the larynx or may have spread to one nearby lymph node. The treatment becomes more complex, often requiring a combination of therapies, but more than half of patients still survive five years or longer.^[17]

For Stage 4 disease, which may have spread into tissues outside the larynx, to multiple or distant lymph nodes, or to other parts of the body, almost 35 out of 100 adults (almost 35 percent) survive for five years or more. While this survival rate is lower, it’s important to remember that these are averages based on groups of people, and individual outcomes can vary widely. Advances in treatment continue to improve outcomes even for advanced disease.^[17]

It’s crucial to understand that survival statistics are estimates based on large groups of people and cannot predict what will happen to any individual. Your personal prognosis depends on many factors unique to you, including your specific tumor characteristics, overall health, response to treatment, and access to comprehensive care. These statistics also reflect outcomes from people diagnosed several years ago, and treatments continue to improve. Your healthcare team can provide more personalized information about your outlook based on your specific situation.^[17]

#1 Clinical Trials Search in Europe